NCT00352105 · OUTCOME

Number of Patients With a Complete Response Defined as Complete Disappearance of All Clinically Detectable Tumor.

Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck Cancer · Source last updated 2012-11-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: NUMBER
Unit: participants
Interval / dispersion: Not reported
Time frame: 3 years

What was measured

Complete response rate per RECIST Criteria (CTC V3)

Analysis population: 5 early deaths were not evaluable

Groups in this outcome

5-FU, Cisplatin, Radiation and Iressa

Patients undergo hyperfractionated radiotherapy twice daily, 5 days a week, beginning on day 1 and continuing for 6 weeks. Patients also receive fluorouracil IN continuously over 96 hrs. and cisplatin IV continuously over 96 hrs. on days 1-3 and 22-25 and oral gefitinib beginning once daily on day 1 and continuing for up to 2 years in the absence of disease progression or unacceptable toxicity.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
5-FU, Cisplatin, Radiation and Iressa	55

Reported measurements

Source class 1

Values in participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
5-FU, Cisplatin, Radiation and Iressa	42	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
value
42

denoms

counts
group Id
OG000
value
55
units
Participants

description

Complete response rate per RECIST Criteria (CTC V3)

groups

description
Patients undergo hyperfractionated radiotherapy twice daily, 5 days a week, beginning on day 1 and continuing for 6 weeks. Patients also receive fluorouracil IN continuously over 96 hrs. and cisplatin IV continuously over 96 hrs. on days 1-3 and 22-25 and oral gefitinib beginning once daily on day 1 and continuing for up to 2 years in the absence of disease progression or unacceptable toxicity.
id
OG000
title
5-FU, Cisplatin, Radiation and Iressa

param Type

NUMBER

population Description

5 early deaths were not evaluable

reporting Status

POSTED

time Frame

3 years

title

Number of Patients With a Complete Response Defined as Complete Disappearance of All Clinically Detectable Tumor.

type

SECONDARY

unit Of Measure

participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice